6Ezzat AA, Ibrahim EM, Stuart RK,et al. Adding high -dose tamoxifen to CHOP does not influence response or survival in aggressive non - Hodgkin, s Lymphoma: an interim analysis of a randomized phase Ⅲ tria [ J]. Med Oncol,2000,17 ( 1 ) :39 -46.
7储大同.淋巴瘤的治疗进展[J].中国肿瘤,1995,4:23-23.
8Fisher R I, Gaynor E R, Dahlerg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma[J]. N Engl J Med, 1993, 328:1002.
9Gorndon L, Harrington D, Anderson J, et al. Comparison of a second-generation combination chemotherapy regimen (m-BACOD) with a stardard regimen (CHOP) for advanced diffuse nonHodgkin's lymphoma[J]. N Engl J Med, 1992, 327:1342.
10Tone H, Kurebe M, Takeuchi T, et al. Experimental studies on(2"R)4'-0-Tetrahydropyranyladriamycin (THP)[A]. In Kuemmerle HP ed. Advance in experimental and clinical chemotherapy[M]. Landsbeg/Lech: Ecomed, 1988 : 1-9.
